Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal
- BOND RX™ Validated
- 20ul selling size
- KO Validated
- RabMAb
- Recombinant
- What is this?
4
(7 Reviews)
|
(263 Publications)
Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) is a rabbit monoclonal antibody detecting CDKN2A/p16INK4a in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 190 publications
View Alternative Names
CDKN2, MTS1, CDKN2A, Cyclin-dependent kinase inhibitor 2A, Cyclin-dependent kinase 4 inhibitor A, Multiple tumor suppressor 1, p16-INK4a, CDK4I, MTS-1, p16-INK4, p16INK4A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue labeling CDKN2A/p16INK4a with unpurified ab108349 at a dilution of 1/250.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Formalin-fixed, paraffin-embedded human normal breast, luminal-A DCIS (ductal carcinoma in situ) and triple negative breast cancer tissues stained for CDKN2A/p16INK4a using ab108349 in immunohistochemical analysis.
Image from Shan M et al., PLoS One. 2013;8(10):e76408. Fig 1.; doi: 10.1371/journal.pone.0076408. eCollection 2013. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Immunohistochemical analysis of formalin fixed paraffin embedded human testis labelling CDKN2A/p16INK4a with ab108349 at a concentration of 1µg/ml. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20mins.
ab108349 anti-CDKN2A/p16INK4a antibody [EPR1473] was incubated for 15mins at room temperature. Sections were counterstained with Hematoxylin. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Flow cytometry overlay histogram showing left HeLa positive cells and right negative MCF7 stained with ab108349 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab108349) (1x 106 in 100μl at 0.04μg/ml (1/52500)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Intracellular Flow Cytometry analysis of HEK-293 (Human epithelial cell line from embryonic kidney) cells labeling CDKN2A/p16INK4a with purified ab108349 at 1/270 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabeled control, cells without incubation with primary and secondary antibodies.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervix carcinoma tissue labeling CDKN2A/p16INK4a with purified ab108349 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, an HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500).
Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Overlay histogram showing HEK-293 (Human epithelial cell line from embryonic kidney) cells stained with unpurified ab108349 (red line). The cells were fixed with 4% paraformaldehyde (10 minutes) and then permeabilized with 0.1% PBS-Tween for 20 minutes. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab108349 1/100) for 30 minutes at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 minutes at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5000 events was performed. This antibody gave a positive signal in HEK-293 cells fixed with 80% methanol (5 minutes)/permeabilized with 0.1% PBS-Tween for 20 minutes used under the same conditions.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Immunohistochemical analysis of formalin fixed paraffin embedded human testis labelling CDKN2A/p16INK4a with ab108349 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab108349 anti-CDKN2A/p16INK4a antibody [EPR1473] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
- IP
Lab
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
ab108349 (purified) at 1/30 immunoprecipitating CDKN2A/p16INK4a in HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate. For western blotting, a peroxidase-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/1000).
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349)
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Western blot : Anti-CDKN2A antibody [EPR1473] (ab108349) staining at 1/4000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab108349 was shown to bind specifically to CDKN2A. A band was observed at 17 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in CDKN2A knockout cell line. To generate this image, wild-type and CDKN2A knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) at 1/4000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
CDKN2A knockout HEK-293T cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) at 1/2000 dilution
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
- WB
Unknown
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Lane 2:
HEK-293T (Human epithelial cell line from embryonic kidney) cell lysate at 10 µg
Lane 3:
Saos-2 (Human osteosarcoma cell line) cell lysate at 10 µg
Predicted band size: 17 kDa
false
- WB
Lab
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) at 1/2000 dilution
Lane 1:
HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate at 10 µg
Lane 2:
Saos-2 (Human osteosarcoma cell line) cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
Tissue Microarrays stained for "Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal" using "ab108349"in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pre-treated using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. The sections were incubated with ab108349 for 30 mins at room temperature followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- WB
Supplier Data
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (AB108349)
5% NFDM/TBST was used as a blocking and diluting buffer.
All lanes:
Western blot - Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) at 1/1000 dilution
Lane 1:
Human CDKN2A full-length recombinant protein with His-tag at 0.01 µg
Lane 2:
Human CDKN2B full-length recombinant protein with GST-tag at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 17 kDa
Observed band size: 17 kDa
false
Exposure time: 10s
Related conjugates and formulations (3)
-
578 PE
PE Anti-CDKN2A/p16INK4a antibody [EPR1473]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CDKN2A/p16INK4a antibody [EPR1473]
-
Anti-CDKN2A/p16INK4a antibody [EPR1473] - BSA and Azide free
Reactivity data
Product details
Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IHC-P, IP and WB.
Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) was first used in a scientific publication in 2013 and has been cited over 192 times in peer reviewed journals. It's performance in Western Blot and IHC in human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has been confirmed by Western Blot testing in CDKN2A/p16INK4a knockout HEK-293T cells.
Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) has 6 independent reviews from customers.
Anti-CDKN2A/p16INK4a antibody [EPR1473] - C-terminal (ab108349) specifically detects CDKN2A/p16INK4a (UniProt ID: P42771; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EPR1473 - ab186932.
Antibody clone EPR1473 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, PE (ab192054, ab209579).
CDKN2A, encoding the tumor suppressor protein p16INK4a, plays a crucial role in regulating the cell cycle by inhibiting cyclin-dependent kinases, thereby preventing uncontrolled cell proliferation. Mutations or deletions in CDKN2A are frequently associated with various cancers, including melanoma, pancreatic cancer and head and neck squamous cell carcinoma.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (263)
Recent publications for all applications. Explore the full list and refine your search
Translational cancer research 14:4939-4954 PubMed40950681
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadu2294 PubMed40680126
2025
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 6:e70205 PubMed40636284
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40564900
2025
Applications
Unspecified application
Species
Unspecified reactive species
MedComm 6:e70261 PubMed40547942
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular oncology (Dordrecht, Netherlands) 48:1363-1375 PubMed40522623
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 12:1451056 PubMed40357269
2025
Applications
Unspecified application
Species
Unspecified reactive species
npj aging 11:35 PubMed40348751
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eads1875 PubMed40279419
2025
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 26:138 PubMed40223048
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com